首页 / 专利分类库 / 有机化学 / 杂环化合物 / 杂环化合物,含有1-氮杂二环〔3.2.0〕庚烷环系,即含下式环系的化合物: / ·有杂原子或3个键连杂原子至多1个键连卤素的碳原子,例如酯基或氰基,直接连在位置4
序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
1 JPH0215552B2 - JP12792778 1978-10-19 JPH0215552B2 1990-04-12 BAATON JII KURISUTENSEN; DEIUITSUDO BII AARU JONSUTON; SUUZAN EMU SHUMITSUTO
2 Carbapenems JP14068185 1985-06-28 JPS6118779A 1986-01-27 ANDORE FURENMAIAA; ERUBIN GETSUCHI
3 Carba-2-penem compound and its preparation JP11498681 1981-07-21 JPS5793981A 1982-06-11 MORIMOTO AKIRA; MIYAWAKI TOSHIO; YOSHIOKA KOUICHI
NEW MATERIAL:The compound of formulaI(R 1 is alkyl, aryl, alkylthio, arylthio or acylaminoalkylthio; R 2 and R 3 are alkoxycarbonyl, cyano or COR 1; R 3 may be alkyl or aryl; R 4 is H, alkyl, hydroxyalkyl, aryl, or amino), its salt and ester. EXAMPLE: 1-Acetyl-1, 2-dimethyl-6-( 1-hydroxy-1-methylethyl )-carba-2-penem-3-carboxilic acid. USE: Antibacterial agent. It is added to an animal feed, industrial water, etc. as a disinfectant. PROCESS: The compound of formulaIcan be prepared by the cyclization of the compound of formula II (Z is phosphonio or phosphono) which is obtained from a novel compound of formula III. The compound of formula III is prepared by reacting the compound of formula IV with the compound of formula V. COPYRIGHT: (C)1982,JPO&Japio
4 JPH0367068B2 - JP5927984 1984-03-27 JPH0367068B2 1991-10-21 SUGIMURA MASAO; HASHIMOTO TOSHIHIKO; TANAKA TERUO; IINO KIMIO; SHIBATA TOMOYUKI; IWATA MASAYUKI
5 1-hetero-6-(1-hydroxyethyl)-2-sr8-1- carbadethiapen-2-em-3-carboxylic acid JP8560985 1985-04-23 JPS60233077A 1985-11-19 ROBUJI DEE KAMA; BAATON JII KURISUTENSEN; DEIBUITSUDO ETSUCHI SHIII
6 1-substituted carbapenem-3-carboxylic acid derivative and its preparation JP5927984 1984-03-27 JPS60202886A 1985-10-14 SUGIMURA MASAO; HASHIMOTO TOSHIHIKO; TANAKA TERUO; IINO KIMIO; SHIBATA TOMOYUKI; IWATA MASAYUKI
NEW MATERIAL:A carbapenem derivative of formula I [R 1, R 2 are H where they are not Hs at a time, 1W10C alkyl which may be substituted, alkenyl, alkoxy or they incorporate to form a 3W6-membered ring, halogen; R 3 is (substituted) 4W8-membered ring of carbon atoms which may be interrupted with N, S, O, sulfinyl or sulfonyl; R 4 is H, COOH-protecting group; R 5 is H, 1W6C alkyl which may be substituted, alkoxy] and its salt. EXAMPLE: p-Nitrobenzyl (1S, 5R, 6S, 8R)-1-methyl-2-[(R)-1-(N-p-nitrobenzyloxycarbonylacetimidoyl)pyrrolidin-3-ylthio]-6-( 1-hydroxyethyl )-2-carbapenem-3-carboxylate. USE: Antibacterial or its synthetic intermediate. PREPARATION: A compound of formula III is converted into a compound of formula IV (R 6 is alkanesulfonyl) which is allowed to react with R 3SH. COPYRIGHT: (C)1985,JPO&Japio
7 33substitutedd66substitutedd77oxoo11 azabicyclo*3*2*0**heptaa22enee22carboxylic acid JP12792778 1978-10-19 JPS5466697A 1979-05-29 BAATON JII KURISUTENSEN; DEIBUITSUDO BII AARU JIYONSUTO; SUUZAN EMU SHIYUMITSUTO
8 33substitutedd66*1**hydroxyethyl**77oxoo11 azabicyclo*3*2*0**heptoo22enee22carboxylic acid JP12792678 1978-10-19 JPS5466696A 1979-05-29 BAATON JII KURISUTENSEN; DEIBUITSUDO BII AARU SHIYONSUT; SUUZAN EMU SHIYUMITSUTO
9 Carbapenem compound JP9975091 1991-04-05 JPH04234884A 1992-08-24 SUKOTSUTO RUISU DATSUKUSU; DENISU DORUTON KIISU; PAMERA RORIIN ROSUMAN
PURPOSE: To provide the novel compd. useful as an antibacterial agent. CONSTITUTION: This compd. is expressed by formula I (R is H, carboxylic acid protective group; R 1 is H lower alkyl, etc.; R 2, R 3 are each H, lower alkoxy, etc.; Y is ester, piperadinyl, etc.; where this ester is bonded to substd. quinolonyl, etc., and further, the piperadinyl includes a piperadinyl nucleus having an N atom to be bonded to naphthylidony, etc.), its ester, its salt and its hydrate; for example, raceme-[5R,6S(R)]-3-[[[6,8-difluoro-1-(2-fluoroethyl)-1, 4-dihydro-4-oxo-7-(4-methyl-1-piperadinyl-3-quinolonyl]carbonyl]oxy]methyl-6-(1- hydroxyethyl)-7-oxo-1-azabicyclo-[3,2,0]hep-2-ten-carboxylic acid. The compd. is obtd. by bringing, for example, the compd. of formula II (R 6 is an ester residue; X is H) into reaction with substd. isothiazoloquinolone. COPYRIGHT: (C)1992,JPO
10 JPH0438753B2 - JP12792678 1978-10-19 JPH0438753B2 1992-06-25
11 JPH0419230B2 - JP13651479 1979-10-24 JPH0419230B2 1992-03-30 BAATON JII KURISUTENSEN; DEIUITSUDO ETSUCHI SHIII
12 JPS6319514B2 - JP13735777 1977-11-17 JPS6319514B2 1988-04-22 BAATON JII KURISUTENSEN; DEIUITSUDO BII AARU JONSUTON; SUUZAN EMU SHUMITSUTO
13 66*11 and 22substitutedd11carbadethiapenee22 emm33carboxylic acids JP13651479 1979-10-24 JPS5589285A 1980-07-05 BAATON JII KURISUTENSEN; DEIBUITSUDO ETSUCHI SHIII
14 33*22aminoethylthio**66*11hydroxyethyl* 77oxoo11azabicyclo*3*2*0*heptt22 enee22carboxylate JP13735777 1977-11-17 JPS5365892A 1978-06-12 BAATON JII KURISUTENSEN; DEIBUITSUDO BII AARU JIYONSUTO; SUUZAN EMU SHIYUMITSUTO
15 고정상 연속흐름반응을 이용한 페넴계 유도체의 제조 방법 KR1020180111070 2018-09-17 KR1020200031934A 2020-03-25
16 Atypical Carbapenem Antibiotics with Improved Activity Against Carbapenemase-Producing Acinetobacter baumannii US16839049 2020-04-02 US20200339582A1 2020-10-29 John Buynak; Sergei Vakulenko; Maha Alqurafi; Noora Al-Kharji; Marta Toth; Nichole Stewart
The following invention deals with the design, preparation, evaluation, and use of carbapenem antibiotics with improved activity, relative to current commercially available carbapenem antibiotics, against infections involving multidrug resistant, carbapenemase-producing Acinetobacter baumannii. The new carbapenem antibiotics are demonstrated to possess not only inherent antimicrobial activity, but also the ability to inhibit OXA-23, the most commonly produced serine carbapenemase in this species. This unusual carbapenemase-inhibitory activity also indicates that the compounds may be used synergistically, in combination with current commercial carbapenem antibiotics, to inhibit key class D carbapenemases, such as OXA-23. Additionally, one of the newly reported carbapenems is active against metallo-beta-lactamase producing A. baumannii. This is the first report of a metallo-beta-lactamase stable carbapenem antibiotic. Structurally, the present invention describes carbapenem antibiotics which are modified in unusual ways, thus differentiating them from the common scaffold of all current commercial carbapenem antibiotics. In particular, these carbapenems have either an unusual C6 substituent, a hydroxymethyl group, replacing the common hydroxyethyl group, or they have an unusual C5 substituent, an alkyl group, replacing the common hydrogen atom at this position. Such atypical carbapenem antibiotics have not previously been investigated against resistant A. baumannii, nor have they been evaluated for stability to the class D carbapenemase, or the class B metallo-beta-lactamases.
17 2,5-DISUBSTITUTED 3-METHYL PYRAZINES AND 2,5,6-TRISUBSTITUTED 3-METHYL PYRAZINES AS ALLOSTERIC SHP2 INHIBITORS US16228324 2018-12-20 US20190210977A1 2019-07-11 Ashutosh JOGALEKAR; Walter WON; Elena S. KOLTUN; Adrian GILL; Kevin MELLEM; Naing AAY; Andreas BUCKL; Christopher SEMKO; Gert KISS
The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.
18 METHOD FOR THE PREPARATION OF CARBAPENAM COMPOUNDS US13985478 2012-02-14 US20140148595A1 2014-05-29 Marek Chmielewski; Bartlomiej Furman; Sebastian Stecko; Irma Panfil; Margarita Jurezak; Paulina Mikolajezyk; Magdalena Soluch
The subject of the present invention is a method of the preparation of compounds containing the core skeleton of carbapenem antibiotics, novel intermediate compounds used in this method, a method of the preparation of the intermediate compounds as well as the use of the intermediate compounds in the production of carbapenem antibiotics.
19 6- (spirocyclopropyl) penicillanic acid 4, 4-dioxides US09771440 2001-01-26 US20020147178A1 2002-10-10 Vincent P. Sandanayaka; Amarnauth S. Prashad
The 6-(spirocyclopropyl)-penicillanic acid 4,4-dioxides of the general Formula (I): 1 as defined herein above which exhibit beta-lactamase inhibiting activity, use of such compounds in combination with beta-lactam antibiotics for inhibiting beta-lactamases, pharmaceutical compositions and processes for preparing such compounds.
20 2-(1-aceti midoyl-5-carbamoylpyrrolidin-3-ylthio-6-(1-hydroxyethyl)-1-methylcarbapen -2-em-3-carboxylic acid US463773 1990-01-05 US5102997A 1992-04-07 Yukio Sugimura; Toshihiko Hashimoto; Teruo Tanaka; Kimio Iino; Tomoyuki Shibata; Masayuki Iwata
Compounds of formula (I): ##STR1## wherein: one or both of R.sup.1 and R.sup.2 are selected from a variety of organic groups;R.sup.3 is an optionally substituted heterocycle; andR.sup.4 is hydrogen or optionally substituted alkyl or alkoxy.and salts and esters thereof have valuable antibiotic activity.
QQ群二维码
意见反馈